BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Latest News

This Company Open Sources The Largest AI Foundation Models for Pathology

by Andrii Buvailo, PhD  (contributor )   •   Aug. 1, 2024  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# AI & Digital   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Paige, an AI-powered pathology solutions provider, has announced the open-source release of its AI models, Virchow and PRISM. Available on Hugging Face, these models are designed to aid researchers, diagnosticians, and developers in cancer research.

#advertisement
AI in Drug Discovery Report 2025

Virchow, developed in collaboration with Microsoft Research, is the first million-slide example of foundation models for cancer. It utilizes a dataset of 1.5 million digitized pathology slides from Memorial Sloan Kettering Cancer Center, offering insights into cancer diagnosis and management practices.

Image credit: Paige

PRISM builds on Virchow’s framework by combining vision and language models to provide slide-level cancer insights. Trained with an additional 587,000 whole slide images and 195,000 clinical reports, PRISM generates diagnostic summaries. These summaries assist in standard diagnostic tasks such as cancer detection and subtyping, and aim to improve efficiency by reducing the need for extensive training data.

Paige’s decision to open-source these models under various licenses is intended to promote collaboration and innovation within the research community. Virchow is available under the Apache 2.0 License, while PRISM and the Paige ML SDK are accessible under the CC-BY-NC-ND 4.0 License.

Siqi Liu, Director of AI Science at Paige, commented:

“Our goal is to support progress in AI research by making our models accessible... The release of OpenPFM, featuring Virchow and PRISM, is part of our efforts to improve cancer diagnosis and treatment.”

For those interested in more advanced versions or commercial licensing, Paige provides solutions to support clinical trials, research and development, and other commercial applications. The company also offers collaboration opportunities with its team of AI scientists and medical experts to support scientific discoveries.

RELATED: 14 Companies Pioneering AI Foundation Models in Pharma and Biotech

Paige uses AI technology to enhance cancer discovery and treatment, aiming to improve diagnostic accuracy and efficiency worldwide. As the first company to receive FDA approval for a clinical AI application in digital pathology, Paige continues to integrate AI with medical research and clinical applications.

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.